Full Breakdown
American Medical Association Reaffirms Support for Gender-Affirming Care Amid Controversy
4/1/2026, 11:43:14 PM
Core Event: AMA's Position on Gender-Affirming Care
The American Medical Association (AMA) has reaffirmed its support for gender-affirming care, asserting that its policies remain unchanged despite recent media reports suggesting otherwise. This clarification comes in response to articles published by The New York Times, which claimed that the AMA had shifted its stance on surgeries for transgender minors, aligning with the American Society of Plastic Surgeons (ASPS) in endorsing restrictions on such procedures.
Background & Context: Media Misinterpretation
The controversy began when The New York Times reported in February and March that the AMA had newly endorsed limitations on gender-affirming surgeries for individuals under 18. The AMA's Board of Trustees chair, Dr. David Aizuss, countered these claims, stating that the organization had not changed its policy and that the media's interpretation overstated its position. Aizuss emphasized that while surgeries for minors are generally deferred until adulthood, this does not reflect a withdrawal of support for gender-affirming care as a whole, which includes counseling and hormone therapy.
Official Statements & Responses
In a newsletter, Dr. Aizuss stated, “There has been no change in AMA policy with respect to access to and provision of gender-affirming care.” He further clarified that the AMA does not endorse the ASPS's position statement, which recommends delaying surgeries for minors until they are at least 19 years old. The AMA has requested corrections from The New York Times regarding its coverage, asserting that the mischaracterization has led to confusion and political ramifications.
Criticism & Opposition: Political and Legal Challenges
Critics, including Alex Sheldon, executive director of GLMA: Health Professionals Advancing LGBTQ+ Equality, argue that the political climate has exploited the perceived uncertainty surrounding gender-affirming care to justify restrictions. Sheldon stated, “The federal government is using its own power to try to undermine medical integrity, expertise, and science.” Legal challenges have emerged, with courts rebuffing attempts to limit access to transgender healthcare, reinforcing the consensus that gender-affirming care is medically necessary.
Conflicting Reports & Gaps
While the AMA maintains its support for gender-affirming care, the ASPS's position statement has been cited by anti-trans activists as evidence of a shift in medical consensus. This has led to a broader debate about the interpretation of medical guidelines and the impact of media narratives on public policy. The discrepancy between the AMA's official stance and the ASPS's recommendations highlights the ongoing tensions within the medical community regarding transgender healthcare.
Verbatim Quotes
- “There has been no change in AMA policy with respect to access to and provision of gender-affirming care,” — Dr. David Aizuss, Chair, AMA Board of Trustees
- “The federal government is using its own power to try to undermine medical integrity, expertise, and science,” — Alex Sheldon, Executive Director, GLMA
What's Next: Ongoing Discussions and Legislative Actions
As the AMA continues to clarify its position, discussions surrounding gender-affirming care are likely to persist in both medical and political arenas. The implications of the ASPS's position statement may influence upcoming votes within medical societies, such as the Medical Society of the State of New York, where proposals to endorse similar restrictions are being considered. The outcome of these discussions will be critical in shaping the future of transgender healthcare access.
